Prentki, E. S., Caniffi, C., Bouchet, G., González, D. M., Toblli, J., Costa, M., & Arranz, C. (2015). C-type natriuretic peptide chronic administration attenuates cardiac fibrosis and inflammation in spontaneously hypertensive rats. BMC Pharmacol Toxicol.
Stile di citazione ChicagoPrentki, E Santos, C. Caniffi, G. Bouchet, D Maglio González, J. Toblli, MA Costa, e C. Arranz. "C-type Natriuretic Peptide Chronic Administration Attenuates Cardiac Fibrosis and Inflammation in Spontaneously Hypertensive Rats." BMC Pharmacol Toxicol 2015.
Citazione MLAPrentki, E Santos, et al. "C-type Natriuretic Peptide Chronic Administration Attenuates Cardiac Fibrosis and Inflammation in Spontaneously Hypertensive Rats." BMC Pharmacol Toxicol 2015.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.